Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine for prevention of chronic musculoskeletal pain (ATTAC-Pain)
NCT03315533Phase 2Completed
- Sponsor
- Rhode Island Hospital
- Start
- Jan 2018
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of duloxetine in Musculoskeletal pain, sponsored by Rhode Island Hospital. Started Jan 2018; status: completed.
02
Drugs
duloxetine
03
Conditions
Musculoskeletal pain
Beyond the preview
Go deeper on NCT03315533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03315533.